Literature DB >> 14871647

Genetic basis of murine lupus.

Marie-Laure Santiago-Raber1, Catherine Laporte, Luc Reininger, Shozo Izui.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by the formation of a variety of autoantibodies and subsequent development of severe glomerulonephritis. Etiology of SLE remains unknown even if it is now well established that SLE is under polygenic control as well as the contribution of hormonal and environmental factors. The availability of several murine strains that spontaneously develop an autoimmune syndrome resembling human SLE, such as New Zealand, MRL and BXSB mice has provided useful tools for the genetic dissection of susceptibility to SLE. Moreover, development of various transgenic and mutant mice has made it possible to identify a number of susceptibility genes such as those involved in the regulation of apoptosis or B cell receptor signaling that can trigger lupus-like phenotypes. Obviously, further identification of the genetic defects present in lupus-prone mice is of paramount importance for understanding the immunopathogenesis of SLE.

Entities:  

Mesh:

Year:  2004        PMID: 14871647     DOI: 10.1016/S1568-9972(03)00062-4

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  27 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Models of chronic kidney disease.

Authors:  Hai-Chun Yang; Yiqin Zuo; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2010

Review 3.  Interferon-inducible Ifi200-family genes in systemic lupus erythematosus.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Immunol Lett       Date:  2008-07-01       Impact factor: 3.685

4.  Gene expression profiles in a rabbit model of systemic lupus erythematosus autoantibody production.

Authors:  Geeta Rai; Satyajit Ray; Jacqueline Milton; Jun Yang; Ping Ren; Richard Lempicki; Rose G Mage
Journal:  J Immunol       Date:  2010-09-03       Impact factor: 5.422

5.  In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.

Authors:  Heike Albert; Mattias Collin; Diana Dudziak; Jeffrey V Ravetch; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

Review 6.  Dysregulation of T Follicular Helper Cells in Lupus.

Authors:  John D Mountz; Hui-Chen Hsu; Andre Ballesteros-Tato
Journal:  J Immunol       Date:  2019-03-15       Impact factor: 5.422

7.  Neuropsychiatric lupus and association with cerebrospinal fluid immunoglobulins: a pilot study.

Authors:  Ljudmila Stojanovich; Dusica Smiljanich-Miljkovich; Roald Omdal; Boris Sakic
Journal:  Isr Med Assoc J       Date:  2009-06       Impact factor: 0.892

8.  Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes.

Authors:  Thomas B Sundberg; Lara Swenson; Daniel R Wahl; Anthony W Opipari; Gary D Glick
Journal:  J Pharmacol Exp Ther       Date:  2009-08-25       Impact factor: 4.030

9.  Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus.

Authors:  Xiaoliang He; Yunlong Zhang; Ai Zhu; Kang Zeng; Xiuping Zhang; Li Gong; Yusheng Peng; Kuan Lai; Shaogang Qu
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

10.  Regulation of B cell tolerance by 129-derived chromosome 1 loci in C57BL/6 mice.

Authors:  Liliane Fossati-Jimack; Josefina Cortes-Hernandez; Peter J Norsworthy; H Terence Cook; Mark J Walport; Marina Botto
Journal:  Arthritis Rheum       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.